AXLA stock forecast
Our latest prediction for Axcella Health, Inc.'s stock price was made on the Jan. 31, 2020 when the stock price was at 4.84$.
In the short term (2weeks), AXLA's stock price should underperform the market by -1.61%. During that period the price should oscillate between -11.15% and +14.92%.
In the medium term (3months), AXLA's stock price should underperform the market by -4.47%. During that period the price should oscillate between -43.43% and +36.16%.Get email alerts
About Axcella Health, Inc.
Axcella Health, Inc. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Its product pipeline includes AXA1665, AXA1125, AXA1957, AXA2678, and AXA4010. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.29$ per share.
The book value per share is 3.22$
Three months stock forecastJan. 31, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|